Rising Resistance to GSK's Dolutegravir Sparks Concern in HIV Treatment Landscape
|
The WHO reports growing resistance to dolutegravir, a key
HIV drug by GSK, raising concerns about the future of antiretroviral
therapy and the ... |
Iwi Māori partnership boards prepping for collective action
Hikitia Ropata, chair of the Porirua-based Āti Awa Toa Hauora Iwi Māori Partnership Board, says with the Government likely to soon begin pushing ... View article...